Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Regular Internet Use May Reduce Dementia Risk in Older Adults
07/12/2023
Older adults who used the internet regularly had about half the risk of dementia compared with their peers who did not, according to a study published online in the Journal of the American Geriatrics Society. “Online engagement may help to...
Older adults who used the internet regularly had about half the risk of dementia compared with their peers who did not, according to a study published online in the Journal of the American Geriatrics Society. “Online engagement may help to...
Older adults who used the...
07/12/2023
Psych Congress Network
News
High Post-Stroke Glucose Levels Linked With Faster Cognitive Decline
07/12/2023
High post-stroke glucose levels were associated with faster cognitive decline in a recent meta-analysis published in JAMA Network Open. “These findings suggest that higher cumulative glucose levels may contribute to faster cognitive...
High post-stroke glucose levels were associated with faster cognitive decline in a recent meta-analysis published in JAMA Network Open. “These findings suggest that higher cumulative glucose levels may contribute to faster cognitive...
High post-stroke glucose levels...
07/12/2023
Neurology
Pregnant person getting their blood pressure checked
News
Fertility Treatment Does Not Raise MS Relapse Risk, Study Finds
07/10/2023
Patients with multiple sclerosis undergoing fertility treatments were not found to be at an elevated relapse risk following treatment, according to a study published in Neurology Neuroimmunology & Neuroinflammation.
Patients with multiple sclerosis undergoing fertility treatments were not found to be at an elevated relapse risk following treatment, according to a study published in Neurology Neuroimmunology & Neuroinflammation.
Patients with multiple sclerosis...
07/10/2023
Neurology

Advertisement

A rubber stamp that says FDA approved
News
FDA Fully Approves Lecanemab-IRMB For Early Alzheimer Disease Treatment
07/07/2023
The United States Food and Drug Administration (FDA) has granted full, traditional approval to lecanemab-IRMB (Leqembi™) for the treatment of the early stages of Alzheimer disease.
The United States Food and Drug Administration (FDA) has granted full, traditional approval to lecanemab-IRMB (Leqembi™) for the treatment of the early stages of Alzheimer disease.
The United States Food and Drug...
07/07/2023
Psych Congress Network
A neurologist examines brain scans
News
In Weeks After Concussion, Athletes Show Enhanced Sleep on EEG
07/06/2023
Athletes who experienced a sports-related concussion and underwent sleep studies slept better than the population norm in both the acute and subacute phases of their injury.
Athletes who experienced a sports-related concussion and underwent sleep studies slept better than the population norm in both the acute and subacute phases of their injury.
Athletes who experienced a...
07/06/2023
Neurology
A woman neurologist talks to a man patient using a brain model to demonstrate points
News
Merits of Early Blood Pressure Control for ICH Stroke Confirmed by INTERACT3 Trial Findings
06/28/2023
A swift reduction of systolic blood pressure significantly increases the chances of survival without significant impairment in intracerebral hemorrhage (ICH) stroke patients.
A swift reduction of systolic blood pressure significantly increases the chances of survival without significant impairment in intracerebral hemorrhage (ICH) stroke patients.
A swift reduction of systolic...
06/28/2023
Neurology

Advertisement

Tau Present in Synapses of Post-Mortem Brains With Alzheimer Disease
News
Tau Present in Synapses of Post-Mortem Brains With Alzheimer Disease
06/26/2023
In addition to transmitting signals through the brain, synapses appear to be transporting tau in people with Alzheimer disease, according to study findings published online ahead of print in the journal Neuron.
In addition to transmitting signals through the brain, synapses appear to be transporting tau in people with Alzheimer disease, according to study findings published online ahead of print in the journal Neuron.
In addition to transmitting...
06/26/2023
Neurology
A woman sits on the floor with her head in her hands looking stressed out
News
Lifelong Stress Could Contribute to Worse MS Health, Outcomes
06/20/2023
Stressors experienced across the lifespan, including poverty, abuse, and divorce, have been linked with worse health and functional outcomes for people living with multiple sclerosis (MS).
Stressors experienced across the lifespan, including poverty, abuse, and divorce, have been linked with worse health and functional outcomes for people living with multiple sclerosis (MS).
Stressors experienced across the...
06/20/2023
Neurology
A close-up shot of an elderly person's hands resting on a cane
News
Study Uncovers Association Between Sleep Apnea and Lower Brain Volume
06/19/2023
The medial temporal lobe (MTL) region of the brain may be especially vulnerable to reduced volume and other effects of sleep-disordered breathing (SDB), particularly in individuals with amyloid plaques.
The medial temporal lobe (MTL) region of the brain may be especially vulnerable to reduced volume and other effects of sleep-disordered breathing (SDB), particularly in individuals with amyloid plaques.
The medial temporal lobe (MTL)...
06/19/2023
Neurology

Advertisement

Hyperglycemia After Stroke Associated With Faster Cognitive Decline
News
Hyperglycemia After Stroke Associated With Faster Cognitive Decline
06/15/2023
Higher blood glucose in stroke survivors was associated with faster decline in global cognition, according to a study published online in JAMA Network Open. 
Higher blood glucose in stroke survivors was associated with faster decline in global cognition, according to a study published online in JAMA Network Open. 
Higher blood glucose in stroke...
06/15/2023
Neurology

Advertisement

Advertisement

News

Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
News
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
11/01/2024
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug...
11/01/2024
Neurology
Gene therapy
News
Concerns Linger After Gene Therapy Shows Long-Term Benefit for Cerebral Adrenoleukodystrophy
10/28/2024
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel...
10/28/2024
Neurology
Patient with family
News
During Recovery, Stroke Patients Benefit from Supportive Social Networks
10/24/2024
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and...
10/24/2024
Neurology
International Stroke Burden Saw Hike Over Last 30 Years
News
International Stroke Burden Saw Hike Over Last 30 Years
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has...
10/22/2024
Neurology
Hands holding a head in profile with an illustrated heart over brain
News
Antiseizure Meds May Increase Cardiovascular Risk in Older Adults With Epilepsy
10/21/2024
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy...
10/21/2024
Neurology
FDA approval stamp
News
FDA Approves Infusion Treatment for Advanced Parkinson Disease in Adults
10/18/2024
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa...
10/18/2024
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
News
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
10/15/2024
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to...
10/15/2024
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use